Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
Treatment algorithms for metastatic breast cancer describe sequential treatment with chemotherapy and, if appropriate, targeted therapy for as long as the patient receives benefit. The epothilone ixabepilone is a microtubule stabilizer approved as a monotherapy and in combination with capecitabine f...
Main Author: | Nuhad K. Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.617874/full |
Similar Items
-
Ixabepilone: new perspectives for its use in breast cancer
by: A. A. Mescheryakov, et al.
Published: (2018-11-01) -
Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case
by: E. V. Glazkova, et al.
Published: (2019-12-01) -
Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
by: A S Kolbin, et al.
Published: (2018-03-01) -
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
by: Junsha An, et al.
Published: (2021-09-01) -
Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
by: A S Kolbin, et al.
Published: (2017-01-01)